Showing 1 - 10 of 19
The United States Patent and Trademark Office is tasked with reading and reviewing patent applications to determine those applications which qualify for patent protection. Each application is reviewed by a specific patent examiner who should apply the standards of patentability in an even, fair,...
Persistent link: https://www.econbiz.de/10014176893
This article explores the use of artificial intelligence to help define the current test for copyright infringement. Currently, the test for copyright infringement requires the jury or a judge to determine whether the parties’ works are “substantially similar” to each other from the...
Persistent link: https://www.econbiz.de/10013222137
Brand drug manufacturers use large numbers of patents directed towards the same products creating "patent thickets" to delay or deter generic drug entry. In this Perspective, Dr. Tu and Dr. Sarpatwari show that over the past two decades drug companies have been increasing the intensity of...
Persistent link: https://www.econbiz.de/10014357009
A recent study by professors found that women represent only one-third of the top pharmaceutical patent litigators and one-quarter of lawyers who help inventors obtain these valuable pharmaceutical patents. This lack of representation in the pharmaceutical patent field is surprising because...
Persistent link: https://www.econbiz.de/10014359052
Bioprinting is an additive manufacturing process used to create architectures that mimic natural living tissues in form and function. It involves the deposition of bioink, which can include a mixture of living cells, nutrients, and extracellular matrix. The bioink is then deposited onto a...
Persistent link: https://www.econbiz.de/10014359053
This Viewpoint discusses 3 bills introduced recently in Congress that focus on patent eligibility, fraud, and quality and that have major implications for clinical medicine and pharmaceutical development.Link to full text at JAMA: https://jamanetwork.com/journals/jama/fullarticle/2800700
Persistent link: https://www.econbiz.de/10014359054
This paper evaluates the potential impact of the Supreme Court’s upcoming decision on antibody patents and patent law’s enablement requirement on patient access to new drugs.This article was published in JAMA at https://jamanetwork.com/journals/jama/fullarticle/2803076
Persistent link: https://www.econbiz.de/10014346525
Less than a handful of casebooks are truly open source, in the sense of being fully modifiable. Patent Law: An Open-Source Casebook is the first patent law casebook that provides adopting professors, students, and others the ability to fully modify its contents. This file comprises the casebook...
Persistent link: https://www.econbiz.de/10013229551
Less than a handful of casebooks are truly open source, in the sense of being fully modifiable. Patent Law: An Open-Source Casebook is the first patent law casebook that provides adopting professors, students, and others the ability to fully modify its contents. This file includes the cover,...
Persistent link: https://www.econbiz.de/10013230697
Examiner interviews are one of the most powerful tools to help both inventors and examiners understand and overcome specific issues during prosecution. Direct discussions between an applicant and an examiner can help bridge the gap between misunderstandings of prior art, the invention or...
Persistent link: https://www.econbiz.de/10013233691